Jump to content
The World News Media

Teva's Huntington drug launch on hold after FDA rejection - FierceBiotech


Health and Medicine

Recommended Posts

  • Administrator
images?q=tbn:ANd9GcSqHXdhYj77-0lutUfy3ub
FierceBiotech

Teva's Huntington drug launch on hold after FDA rejection
FierceBiotech
Teva's $3.5 billion plan to buy Auspex and take the final slap shot needed for a new drug approval has gone awry. The company says that the FDA has rejected its marketing application for SD-809 for chorea, the involuntary motion that afflicts ...
Teva Pharma (TEVA) Receives CRL from FDA for SD-809; No New Trials RequestedStreetInsider.com
Teva receives CRL in response to SD-809 NDASeeking Alpha
FDA Asks Teva for More Information on Huntington's DrugNasdaq
GuruFocus.com
all 7 news articles »

Google

Link to comment
Share on other sites


  • Views 272
  • Replies 0
  • Created
  • Last Reply

Top Posters In This Topic

Popular Days

Top Posters In This Topic

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...




×
×
  • Create New...

Important Information

Terms of Service Confirmation Terms of Use Privacy Policy Guidelines We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.